News Industry News OrbusNeich Announces Enrollment of First Patient in China Recovery Study July 20, 2015
Presentation Complete Revascularization with Hemodynamic Support Presenter: Ehtisham Mahmud July 11, 2015
News Industry News Global Launch of Flextherm, Sorin's Latest Generation of Heating and Cooling Systems July 10, 2015
News Daily News ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS Todd Neale June 22, 2015
News Industry News Terumo Launches The MISAGO® RX Self-Expanding Peripheral Stent To U.S. Market June 18, 2015
News Industry News Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy June 17, 2015
News Daily News Un Meta Análisis Avala el Beneficio de la Revascularización Completa en el Manejo de STEMI Todd Neale June 11, 2015
News Daily News Meta-analysis Supports Benefit of Complete Revascularization in STEMI Todd Neale June 11, 2015
Presentation Complete Revascularization in STEMI and Multivessel Disease Presenter: M. Kowalewski June 10, 2015
News Daily News Washington State Sees Increase in Appropriate PCI After AUC Introduction L.A. McKeown June 08, 2015
News Industry News Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease June 05, 2015
Presentation EuroPCR 2015 Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial Presenter: Ota Hlinomaz May 19, 2015
News Conference News EuroPCR 2015 PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI Caitlin E. Cox May 19, 2015
News Industry News New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years May 19, 2015
News Conference News EuroPCR 2015 DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk Yael L. Maxwell May 19, 2015
News Industry News EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment May 19, 2015